a 3.0T Magnetic Resonance Imaging Study
The Central Nerve System Injury in Patients With Primary Open Angle Glaucoma
1 other identifier
observational
200
0 countries
N/A
Brief Summary
Glaucomatous damage not only occurred to retinal ganglion cells in the eyes, but went across optic nerves, visual chiasm, lateral geniculate nucleus (LGN) and finally the visual cortex; the neural degenerations could be identified through the whole visual tract, which suggests the central nerve system may play a vital role in the progression of glaucoma. The investigators used MRI to investigate changes of visual pathway in vivo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2011
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 2, 2011
CompletedFirst Posted
Study publicly available on registry
May 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 3, 2011
May 1, 2011
1.6 years
May 2, 2011
May 2, 2011
Conditions
Eligibility Criteria
All subjects recruited from the Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Clinical ophthalmic assessments including measurement of visual acuities, intraocular pressure, slit-lamp microscopes and funduscopes examinations, cup-to-dick ratio (CDR) evaluation, visual field test \[Octopus 101 Automated Perimeter, Haag-streit, Switzerland. Program G2\], optical coherence tomography for retinal nerve fiber layer thickness(RNFLT) around the optic disk\[Stratus OCT,Carl Zeiss Meditec, Dublin, CA .Scan Type :Fast RNFLT 3.4, Scan Length: 10.87mm\].
You may qualify if:
- Primary open angle glaucoma diagnosed on the basis of glaucomatous optic disc cupping ratio (in particular, thinning of the inferior and/or superior rim, cup-to-disc ratio asymmetry of \>0.2)
- matching glaucomatous visual field defects (European Glaucoma Society (2008) Perimetry )
You may not qualify if:
- optic neuropathy
- neurological disorder
- other diseases and use of systemic medications which affect optic nerve or the visual field underwent complete eye examination and visual-field testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
HONG ZHANG, PHD
Tongji Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 2, 2011
First Posted
May 3, 2011
Study Start
May 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
May 3, 2011
Record last verified: 2011-05